Clinical Trials Browser

Phase 4 × INDUSTRY × Glioblastoma × Clear all

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT05342883 2025-09-05

GESTALT

Phase 4 Active not recruiting

61 enrolled

CNS

Glioblastoma, Glioma, Neoplasms

NCT05900908 2025-04-10

PATHWAyS

Phase 4 Withdrawn

CNS

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00686725 2017-06-14

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Phase 4 Completed

99 enrolled 15 charts

CNS

Glioblastoma

NCT01756729 2016-03-02

Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

Phase 4 Terminated

13 enrolled

CNS

Brain Neoplasms, Glioblastoma, Recurrence

Clinical Trials

Pediatric Long-Term Follow-up and Rollover Study

GESTALT

PATHWAyS

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Post-approval Study of NovoTTF-100A in Recurrent GBM Patients